# Clinical Effectiveness of Nasal Dilators in Sleep-Disordered Breathing: A Systematic Review and Meta-Analysis

**Authors:** Sultan Alotaibi, Bushra Wadi Bin Saddiq, Retaj Sanad Alfarhoud, Saud Turki N. Alghamdi, Amina Jaafar Alsaffar, Abdulaziz Mohammad Alnabhan, Moussa A Alkhateeb, Kawthar Hassan Albahrani, Shahad Ahmed Alowibidy, Zahra Ibrahim Almahdi, Hanin Abdulrahim Almaghrabi, Majed Alnabulsi

PMC · DOI: 10.7759/cureus.100663 · 2026-01-03

## TL;DR

Nasal dilators do not significantly improve sleep-disordered breathing outcomes and are not recommended as a standalone treatment.

## Contribution

This study provides a comprehensive meta-analysis on the clinical effectiveness of nasal dilators for sleep-disordered breathing.

## Key findings

- No significant differences were found in apnea-hypopnea index or other sleep metrics between nasal dilator users and controls.
- Nasal dilators may be useful as an adjunct in mild cases or for nasal congestion.
- The study included 17 studies with 496 participants, providing robust evidence for the lack of monotherapy effectiveness.

## Abstract

Background: Nasal dilators are widely used as a noninvasive intervention for snoring and obstructive sleep apnea (OSA), yet their objective effects on sleep-disordered breathing and polysomnographic outcomes remain uncertain. This systematic review and meta-analysis aim to assess the effectiveness of nasal dilators in managing sleep-disordered breathing.

Methods: Scopus, PubMed, Web of Science, and ProQuest were systematically searched from inception to January 2024 for studies assessing the efficacy of internal or external nasal dilators in adult patients with sleep-disordered breathing. The standardized mean difference (SMD) was used to pool and compare the findings across studies using a random-effects model.

Results: Our search strategy yielded 290 records, of which 17 studies with a pooled population size of 496 participants were found to be eligible for inclusion. We did not find any significant differences in apnea-hypopnea index, apnea index, hypopnea index, snoring index, sleep time, sleep architecture, REM latency, oxygen saturation, and nasal airway resistance between participants who received nasal dilators and control subjects.

Conclusions: Nasal dilators cannot be recommended as monotherapy for sleep-disordered breathing. However, it may be helpful as adjunctive therapy in specific populations with mild symptoms or nasal congestion.

## Linked entities

- **Diseases:** obstructive sleep apnea (MONDO:0007147), sleep-disordered breathing (MONDO:0005296)

## Full-text entities

- **Diseases:** apnea (MESH:D001049), snoring (MESH:D012913), OSA (MESH:D020181), nasal congestion (MESH:D009668), Sleep-Disordered Breathing (MESH:D012891)
- **Chemicals:** oxygen (MESH:D010100), Nasal Dilators (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12761343/full.md

---
Source: https://tomesphere.com/paper/PMC12761343